US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avalyn Pharma

25.76

+0.04000.16%

Post-market: 25.760.00000.00%16:38 EDT

Volume:241.84K

Turnover:6.21M

Market Cap:1.14B

PE:-11.06

High:26.33

Open:25.70

Low:25.22

Close:25.72

52wk High:40.17

52wk Low:24.14

Shares:44.33M

Float Shares:16.67M

Volume Ratio:0.53

T/O Rate:1.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3300

EPS(LYR):-87.7434

ROE:-68.34%

ROA:-41.74%

PB:2.87

PE(LYR):-0.29

Loading ...

Overview Company News Filings

Stock Track | Avalyn Pharma Soars 44.44% in Intraday Trading on Nasdaq IPO Debut

Avalyn Pharma Sets IPO at $18 Per Share to Raise $300 Million, Listing on Nasdaq Tonight

Avalyn Pharma 16.67M share IPO priced at $18.00

BRIEF-Avalyn Announces Pricing Of Upsized Initial Public Offering

Avalyn Announces Pricing of Upsized Initial Public Offering

THOMSON REUTERS

Avalyn Pharma Inc - Prices Upsized IPO of 16,666,667 Shares at $18.00 per Share

THOMSON REUTERS

Avalyn Pharma Sets IPO at 16.7 Million Shares Priced at $16-$18 Each

BRIEF-Avalyn Pharma Now Sees IPO Of 16.7 Million Shares Of Common Stock - SEC Filing

Avalyn Pharma Inc - NOW Sees IPO of 16.7 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS

BRIEF-Avalyn Strengthens Leadership Team To Support Long-Term Growth With Appointments Of Industry Leaders Adam Golden And Frank Salisbury

Avalyn Strengthens Leadership Team to Support Long-Term Growth With Appointments of Industry Leaders Adam Golden and Frank Salisbury

THOMSON REUTERS

Biotech Firm Avalyn Pharma Sets IPO Price Range at $16-$18, Aims to Raise $201 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.etasphere.com/stock/AVLN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":25.76,"timestamp":1791576000000,"preClose":25.72,"halted":0,"volume":241837,"hourTrading":{"tag":"盘后","latestPrice":25.76,"preClose":25.76,"latestTime":"16:38 EDT","volume":4428,"amount":114065.28,"timestamp":1791578288254,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0015552099533438063,"floatShares":16666700,"shares":44333095,"eps":-2.33,"marketStatus":"Market Closed","change":0.04,"latestTime":"10-09 16:00:00 EDT","open":25.7,"high":26.325,"low":25.22,"amount":6210035.5882,"amplitude":0.042963,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":25.72,"preHourTrading":{"tag":"盘前","latestPrice":26.2,"preClose":25.72,"latestTime":"08:48 EDT","volume":526,"amount":13428.730029999999,"timestamp":1791550095497,"change":0.48,"changeRate":0.018663,"amplitude":0.060264},"postHourTrading":{"tag":"盘后","latestPrice":25.76,"preClose":25.76,"latestTime":"16:38 EDT","volume":4428,"amount":114065.28,"timestamp":1791578288254,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5255406719767358,"impliedVol":0.7029,"impliedVolPercentile":0.9143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":-87.743381,"volumeRatio":0.5255406719767358,"shares":44333095,"dividePrice":0,"high":26.325,"amplitude":0.042963,"preClose":25.72,"low":25.22,"week52Low":24.14,"pbRate":"2.87","week52High":40.17,"institutionHeld":0,"latestPrice":25.76,"eps":-2.33,"divideRate":0,"volume":241837,"delay":0,"ttmEps":-2.33,"open":25.7,"prevYearClose":18,"prevWeekClose":28.13,"prevMonthClose":28.49,"prevQuarterClose":28.49,"fiveDayClose":28.13,"twentyDayClose":33.57,"sixtyDayClose":25.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVLN","fiscalQuarterEnding":"2026/06","expectedEps":-1.03,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1791000000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-10-09","current":-11.055794,"percent":0.972973,"low":-16.842577,"twenty":-15.316991,"median":-13.939305,"eighty":-13.086753,"high":-8.833116,"avg":-14.07312,"sd":1.436683,"marketCap":1140247203},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-22","current":-13.941602,"twenty":-14.643344,"median":-13.941602,"eighty":-13.42143,"marketCap":1187880255},{"date":"2026-05-29","current":-13.931787,"twenty":-14.643344,"median":-13.931787,"eighty":-13.215324,"marketCap":1187044014},{"date":"2026-06-05","current":-13.244767,"twenty":-14.510847,"median":-13.774754,"eighty":-13.102456,"marketCap":1128507148},{"date":"2026-06-12","current":-13.774754,"twenty":-14.471589,"median":-13.774754,"eighty":-13.161343,"marketCap":1173664159},{"date":"2026-06-18","current":-14.383258,"twenty":-14.479441,"median":-13.794383,"eighty":-13.204528,"marketCap":1225511097},{"date":"2026-06-26","current":-13.585419,"twenty":-14.649233,"median":-13.936694,"eighty":-13.238878,"marketCap":1284773093},{"date":"2026-07-02","current":-14.143275,"twenty":-14.655122,"median":-14.03484,"eighty":-13.265378,"marketCap":1337529476},{"date":"2026-07-10","current":-13.557292,"twenty":-14.643344,"median":-13.937009,"eighty":-13.265378,"marketCap":1282113107},{"date":"2026-07-17","current":-12.038425,"twenty":-14.576758,"median":-13.784568,"eighty":-13.15846,"marketCap":1138473879},{"date":"2026-07-24","current":-13.937009,"twenty":-14.519455,"median":-13.774754,"eighty":-13.193732,"marketCap":1318022914},{"date":"2026-07-31","current":-13.740119,"twenty":-14.495144,"median":-13.755125,"eighty":-13.157019,"marketCap":1299403014},{"date":"2026-08-07","current":-15.329303,"twenty":-14.523759,"median":-13.762486,"eighty":-13.165961,"marketCap":1449692206},{"date":"2026-08-14","current":-15.696852,"twenty":-14.725787,"median":-13.774754,"eighty":-13.189862,"marketCap":1621704615},{"date":"2026-08-21","current":-15.932863,"twenty":-15.087944,"median":-13.934398,"eighty":-13.227101,"marketCap":1646087817},{"date":"2026-08-28","current":-15.666815,"twenty":-15.573456,"median":-13.941602,"eighty":-13.249768,"marketCap":1618601298},{"date":"2026-09-04","current":-15.207667,"twenty":-15.433025,"median":-14.088821,"eighty":-13.261019,"marketCap":1571164886},{"date":"2026-09-11","current":-14.877252,"twenty":-15.620135,"median":-14.133223,"eighty":-13.26914,"marketCap":1537028403},{"date":"2026-09-18","current":-14.345155,"twenty":-15.433221,"median":-14.265483,"eighty":-13.287874,"marketCap":1482055365},{"date":"2026-09-25","current":-12.251097,"twenty":-15.425244,"median":-14.133223,"eighty":-13.26914,"marketCap":1265709862},{"date":"2026-10-02","current":-11.766203,"twenty":-15.383041,"median":-14.069191,"eighty":-13.181374,"marketCap":1215613464},{"date":"2026-10-09","current":-11.036715,"twenty":-15.316991,"median":-13.939305,"eighty":-13.086753,"marketCap":1140247203}],"updateTime":1791654933176},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVLN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133662273","title":"Stock Track | Avalyn Pharma Soars 44.44% in Intraday Trading on Nasdaq IPO Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1133662273","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133662273?lang=en_us&edition=fundamental","pubTime":"2026-05-01 01:26","pubTimestamp":1777570002,"startTime":"0","endTime":"0","summary":"Avalyn Pharma's stock soared 44.44% in intraday trading on Thursday as the clinical-stage biopharmaceutical company made its trading debut on the Nasdaq Global Select Market.The company's upsized...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115675476","title":"Avalyn Pharma Sets IPO at $18 Per Share to Raise $300 Million, Listing on Nasdaq Tonight","url":"https://stock-news.laohu8.com/highlight/detail?id=1115675476","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115675476?lang=en_us&edition=fundamental","pubTime":"2026-04-30 15:01","pubTimestamp":1777532510,"startTime":"0","endTime":"0","summary":"Avalyn Pharma (AVLN.US), a clinical-stage biotechnology company focused on developing inhaled therapeutics for rare respiratory diseases, has priced its initial public offering at $18 per share. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","NVIW.SI","TQQY","PSQ","JEPQ","QDTE","BK4007","IYW","QQQJ","FTEC","QQQE","QYLG","SQQQ","BK1147","QQQA","GPIQ","QLD","ONEQ","QQQY","QQQ","AVLN","MNQmain","TQQQ","QQQM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631083415","title":"Avalyn Pharma 16.67M share IPO priced at $18.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2631083415","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631083415?lang=en_us&edition=fundamental","pubTime":"2026-04-30 11:35","pubTimestamp":1777520126,"startTime":"0","endTime":"0","summary":"The deal priced at the top end of its $16.00-$18.00 target range. Morgan Stanley, Jefferies, Evercore ISI and Guggenheim are acting as joint book r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-16-67m-share-ipo-priced-at-18-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-16-67m-share-ipo-priced-at-18-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0557290698.USD","LU1668664300.SGD","LU1791710582.SGD","BK4585","LU2111349929.HKD","LU1074936037.SGD","LU1244550577.SGD","LU0912757837.SGD","LU1791710400.SGD","LU0882574139.USD","IPOS","LU0314104364.USD","LU1720051017.SGD","LU1244550221.USD","BK4534","LU0106261372.USD","LU1732799900.SGD","BK4588","LU0225283273.USD","LU1720051108.HKD","BK4127","LU2271345857.HKD","AVLN","LU2347655156.SGD","BK4581","LU0320765646.SGD","LU0795875086.SGD","LU1244550494.USD","LU2357305700.SGD","LU0158827781.USD","LU0098860793.USD","LU1363072403.SGD","IE00BZ1G4Q59.USD","LU0795875169.SGD","LU0528227936.USD","LU1732800096.USD","LU2023251221.USD","LU2133065610.SGD","LU0006306889.USD","LU0267386448.USD","BK4516","LU1989772840.SGD","LU2089283258.USD","LU0158827948.USD","IE00BKVL7J92.USD","LU2089284900.SGD","LU2028103732.USD","LU1162221912.USD","SPCX","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631657927","title":"BRIEF-Avalyn Announces Pricing Of Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2631657927","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631657927?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:05","pubTimestamp":1777511117,"startTime":"0","endTime":"0","summary":"BRIEF-Avalyn Announces Pricing Of Upsized Initial Public OfferingApril 29 (Reuters) - Avalyn Pharma Inc AVLN.O:AVALYN ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERINGAVALYN PHARMA INC - PRICES UPS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA49XTQ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631657919","title":"Avalyn Announces Pricing of Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2631657919","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631657919?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:00","pubTimestamp":1777510853,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA49XTQ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631579417","title":"Avalyn Pharma Inc - Prices Upsized IPO of 16,666,667 Shares at $18.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2631579417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631579417?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:00","pubTimestamp":1777510853,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA49XTQ6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545444","title":"Avalyn Pharma Sets IPO at 16.7 Million Shares Priced at $16-$18 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631545444?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:01","pubTimestamp":1777474860,"startTime":"0","endTime":"0","summary":"Avalyn Pharma on Wednesday plans to sell nearly 16.7 million shares at between $16 and $18 apiece in its initial public offering.At the $17 midpoint of that range, the Boston clinical-stage biopharmaceutical company said it expects net proceeds of about $258.7 million, or roughly $298.2 million if the underwriters exercise an option to buy an additional 2.5 million shares.Avalyn, which is developing inhaled therapies to treat rare respiratory diseases with significant unmet needs, said it believes the proceeds, coupled with its existing resources, will be sufficient to fund its operations into 2029.Avalyn said it would have about 44.3 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $750 million at the $17-a-share pricing midpoint.The company said it has applied to list its shares on the Nasdaq Global Market under the symbol AVLN.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN","SPCX","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545681","title":"BRIEF-Avalyn Pharma Now Sees IPO Of 16.7 Million Shares Of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545681","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631545681?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:53","pubTimestamp":1777474429,"startTime":"0","endTime":"0","summary":"BRIEF-Avalyn Pharma Now Sees IPO Of 16.7 Million Shares Of Common Stock - SEC FilingApril 29  - Avalyn Pharma Inc AVLN.O:AVALYN PHARMA INC - NOW SEES IPO OF 16.7 MILLION SHARES OF COMMON STOCK - SEC FILINGSource text: [ID:n0001193125-26-189477]Further company coverage: AVLN.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C1PC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631151795","title":"Avalyn Pharma Inc - NOW Sees IPO of 16.7 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631151795","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631151795?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:31","pubTimestamp":1777469479,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C1PC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630347391","title":"BRIEF-Avalyn Strengthens Leadership Team To Support Long-Term Growth With Appointments Of Industry Leaders Adam Golden And Frank Salisbury","url":"https://stock-news.laohu8.com/highlight/detail?id=2630347391","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630347391?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:40","pubTimestamp":1777293644,"startTime":"0","endTime":"0","summary":"BRIEF-Avalyn Strengthens Leadership Team To Support Long-Term Growth With Appointments Of Industry Leaders Adam Golden And Frank SalisburyApril 27 (Reuters) - Avalyn Pharma Inc AVLN.O:AVALYN STRENGTHE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA8TNWZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630965423","title":"Avalyn Strengthens Leadership Team to Support Long-Term Growth With Appointments of Industry Leaders Adam Golden and Frank Salisbury","url":"https://stock-news.laohu8.com/highlight/detail?id=2630965423","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630965423?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:00","pubTimestamp":1777291203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA8TNWZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179629143","title":"Biotech Firm Avalyn Pharma Sets IPO Price Range at $16-$18, Aims to Raise $201 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1179629143","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179629143?lang=en_us&edition=fundamental","pubTime":"2026-04-24 15:10","pubTimestamp":1777014645,"startTime":"0","endTime":"0","summary":"Clinical-stage biotech company Avalyn Pharma (AVLN.US), which focuses on developing inhaled therapies for rare respiratory diseases, disclosed the terms of its initial public offering on Thursday....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDN","AVLN","UUP","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":52,"code":"91000000","status":"200"}]}}